Cite
First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft.
MLA
Prat-Vidal, Cristina, et al. “First-in-Human PeriCord Cardiac Bioimplant: Scalability and GMP Manufacturing of an Allogeneic Engineered Tissue Graft.” EBioMedicine, vol. 54, Apr. 2020, p. 102729. EBSCOhost, https://doi.org/10.1016/j.ebiom.2020.102729.
APA
Prat-Vidal, C., Rodríguez-Gómez, L., Aylagas, M., Nieto-Nicolau, N., Gastelurrutia, P., Agustí, E., Gálvez-Montón, C., Jorba, I., Teis, A., Monguió-Tortajada, M., Roura, S., Vives, J., Torrents-Zapata, S., Coca, M. I., Reales, L., Cámara-Rosell, M. L., Cediel, G., Coll, R., Farré, R., … Bayes-Genis, A. (2020). First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft. EBioMedicine, 54, 102729. https://doi.org/10.1016/j.ebiom.2020.102729
Chicago
Prat-Vidal, Cristina, Luciano Rodríguez-Gómez, Miriam Aylagas, Nuria Nieto-Nicolau, Paloma Gastelurrutia, Elba Agustí, Carolina Gálvez-Montón, et al. 2020. “First-in-Human PeriCord Cardiac Bioimplant: Scalability and GMP Manufacturing of an Allogeneic Engineered Tissue Graft.” EBioMedicine 54 (April): 102729. doi:10.1016/j.ebiom.2020.102729.